logo

For the Inventor, By the Inventor

Macrophage Pharma Limited


USPTO Granted Patents = 3



Trademarks = 1

Forward Citations = 1

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal David Festus Charles Moffat (3 out of 16 patents)

silverMedal Stéphane Pintat (2 out of 6 patents)

bronzeMedal Stephen John Davies (2 out of 15 patents)

4.  Martin John Perry (1 out of 1 patent)

5.  Stephen Mark Anderton (1 out of 1 patent)

6.  Clare Louise Doris (1 out of 1 patent)

7.  Carl Leslie North (6 patents)

8.  David Festus Moffat (0 patent)

9.  Stephane Pintat (0 patent)


3 patents:

1. 11382902 - Treatment of cancer by stimulation of IL-12 production (2022-07-12),
2. 10370332 - Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof (2019-08-06),
3. 9896417 - Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof (2018-02-20),
logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

3 Patents

#421 in

#1,346 in

Macrophage Pharma Limited

Forward Citations = 1

6 inventors:

goldMedal David Festus Charles Moffat (3 out of 16 patents)

silverMedal Stéphane Pintat (2 out of 6 patents)

bronzeMedal Stephen John Davies (2 out of 15 patents)

4.  Martin John Perry (1 out of 1 patent)

5.  Stephen Mark Anderton (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com
Loading…